SCHEMBL7101800

SCHEMBL7101800

COc1ccc(NC(=O)[CH]c2ccc(C#N)cc2)cc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
TRPV1 Q8NER1 1/20 0.52
HDAC1 Q13547 1/20 0.51
MAPT P10636 5/20 0.49
TP53 P04637 2/20 0.49
ACHE P22303 1/20 0.48
IMPDH2 P12268 2/20 0.48
IMPDH1 P20839 2/20 0.48
ALDH1A1 P00352 4/20 0.48
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
STAT1 P42224 1/20 0.47
CYP2C9 P11712 1/20 0.47
LMNA P02545 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7101804 0.77 CYP1A2 (0.64) CYP1A2CYP2C19MAPTACHEALDH1A1
SCHEMBL5043916 0.76 TGM2 (0.63) CYP1A2CYP2C19TRPV1HDAC1MAPT
SCHEMBL17693070 0.74 MAPT (0.81) CYP1A2TRPV1HDAC1MAPTTP53
SCHEMBL7615793 0.74 ACHE (0.56) TRPV1HDAC1ACHEIMPDH2IMPDH1
SCHEMBL9865053 0.72 ALDH1A1 (0.70) CYP1A2CYP2C19TP53IMPDH2IMPDH1
Acetone SCHEMBL28054480 0.71 AR (0.57) CYP1A2CYP2C19MAPTALDH1A1MEN1
SCHEMBL10405241 0.71 TRPV1 (0.60) CYP1A2CYP2C19TRPV1HDAC1MAPT
SCHEMBL27783467 0.71 CYP1A2 (0.55) CYP1A2CYP2C19TRPV1HDAC1MAPT
SCHEMBL11348284 0.71 CYP1A2 (0.62) CYP1A2CYP2C19HDAC1MAPTTP53
SCHEMBL8345734 0.70 KMT2A (0.78) CYP1A2CYP2C19HDAC1MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003101941-A2 ALPHA ACYLOXYACETAMIDES FOR KALLIKREIN AND UROKINASE INHIBITION GENZYME CORPORATION (US) 2003-12-11 WO disclosed